AREDS2 stands for Age-Related Eye Disease Study 2, a clinical trial conducted by the National Eye Institute. The study found that a specific combination of vitamins and minerals could help reduce ...

Participants in the AREDS2 study took one of four AREDS2 supplement formulations identified as potentially beneficial in the AREDS study. Each participant took the supplement daily for five years.

Inspired by the AREDs-2 study and enriched with antioxidant-rich plant extracts like bilberry, turmeric, saffron, and ginkgo biloba, iGenics targets the root causes of declining vision—oxidative ...

At the end of the five-year AREDS2 study period, the researchers concluded that lutein and zeaxanthin did not increase risk for lung cancer, and that the new formation could reduce the risk of AMD ...

and the follow-on study AREDS2, which began in 2006. AMD is one of the leading causes of vision loss in adults age 60 and older, according to the National Eye Institute (NEI). By the time people ...

Another smart move, especially for those with wet stage AMD, according to the National Eye Institute AREDs 2 study: Slow progression of dry AMD with a daily supplement formula. The supplements ...

The benefits of the formulation were confirmed in the National Eye Institute’s Age-Related Eye Disease Study (AREDS 2) study, which followed 3,883 individuals with moderate to advanced AMD over ...

The AREDS and AREDS2 studies are landmark clinical studies conducted over 20 years by the NEI. The AREDS study in 2001 demonstrated that taking a specific combination of antioxidants and zinc ...